{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:17:18Z","timestamp":1648959438705},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-535","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T21:01:14Z","timestamp":1408136474000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report"],"prefix":"10.1186","volume":"7","author":[{"given":"Amr S","family":"Omar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Sudarsanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Ewila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kindawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"3067_CR1","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1097\/00001721-200004001-00023","volume":"11","author":"M Al Douri","year":"2000","unstructured":"Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N, Andreasen BR: Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven\u00ae) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 2000, 11: S121-S127.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3067_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2165\/00003495-199549060-00008","volume":"49","author":"R Davis","year":"1995","unstructured":"Davis R, Whittington R: Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs. 1995, 49: 954-983.","journal-title":"Drugs"},{"issue":"3","key":"3067_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/145749690909800302","volume":"98","author":"J Lee","year":"2009","unstructured":"Lee J, Costantini TW, Coimbra R: Acute lower GI bleeding for the acute care surgeon: current diagnosis and management. Scand J Surg. 2009, 98 (3): 135-","journal-title":"Scand J Surg"},{"issue":"4","key":"3067_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/01.mbc.0000224856.95990.c2","volume":"17","author":"AS Zahida","year":"2006","unstructured":"Zahida AS, Al-Shaalan H, Jorgensen J: Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven). Blood Coagul Fibrinolysis. 2006, 17 (4): 327-329.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"3067_CR5","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s10350-007-9086-2","volume":"50","author":"JG Mitchell","year":"2007","unstructured":"Mitchell JG, Speake WJ, Russell NK, Girling K, Armitage NC: Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case. Dis Colon Rectum. 2007, 50 (12): 2238-2240.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"3067_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SMJ.0b013e31804859a4","volume":"100","author":"E Girona","year":"2007","unstructured":"Girona E, Borr\u00e1s-Blasco J, Conesa-Garc\u00eda V, Navarro-Ruiz A, Sol\u00eds J, Garc\u00eda-Sepulcre MF, Oliver-Garc\u00eda I: Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa. South Med J. 2007, 100 (6): 601-604.","journal-title":"South Med J"},{"key":"3067_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0029-7844(03)00349-1","volume":"101","author":"J Danilos","year":"2003","unstructured":"Danilos J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J: Successful treatment with recombinant factor VII for intractable bleeding at pelvic surgery. Obstet Gynecol. 2003, 101: 1172-1173.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"3067_CR8","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1097\/01.CCM.0000181527.47749.57","volume":"33","author":"C von Heymann","year":"2005","unstructured":"von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Spies C: Recombinant activated factor VII for refractory bleeding after cardiac surgery-A retrospective analysis of safety and efficacy. Crit Care Med. 2005, 33 (10): 2241-2246.","journal-title":"Crit Care Med"},{"key":"3067_CR9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V76.9.1680.1680","volume":"76","author":"RC Woodman","year":"1990","unstructured":"Woodman RC, Harker LA: Bleeding complications associated with cardiopulmonary bypass. Blood. 1990, 76: 1680-1697.","journal-title":"Blood"},{"key":"3067_CR10","first-page":"2879","volume":"93","author":"HG Hendricks","year":"2001","unstructured":"Hendricks HG, Van der Maaten JM, de Wolf J, Waterbolk TW, Sloof MJ, Van de Meer J: An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg. 2001, 93: 2879-","journal-title":"Anesth Analg"},{"key":"3067_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/gut.37.2.187","volume":"37","author":"MP Lewis","year":"1995","unstructured":"Lewis MP, Khoo DE, Spencer J: Value of laparotomy in the diagnosis of obscure gastrointestinal haemorrhage. Gut. 1995, 37: 187-190.","journal-title":"Gut"},{"key":"3067_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874300500802010001","volume":"2","author":"MO Guenin","year":"2008","unstructured":"Guenin MO, Peterli R, Kern B, Ackermann C: The use of recombinant coagulation factor VIIa (NovoSeven\u00ae) in severe diverticular bleeding. Open Surg J. 2008, 2: 1-2.","journal-title":"Open Surg J"},{"issue":"6","key":"3067_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjsurg.2009.05.026","volume":"198","author":"JL Howes","year":"2009","unstructured":"Howes JL, Smith RS, Helmer SD, Taylor SM: Complications of recombinant activated human coagulation factor VII. Am J Surg. 2009, 198 (6): 895-899.","journal-title":"Am J Surg"},{"issue":"1","key":"3067_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/hrt.2005.071183","volume":"93","author":"R Roudaut","year":"2007","unstructured":"Roudaut R, Serri K, Lafitte S: Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007, 93 (1): 137-142.","journal-title":"Heart"},{"issue":"18","key":"3067_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJM199305063281801","volume":"328","author":"KE Hammermeister","year":"1993","unstructured":"Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S: A comparison of outcomes in men 11\u00c2 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 1993, 328 (18): 1289-1296.","journal-title":"N Engl J Med"},{"key":"3067_CR16","volume-title":"Cochrane Database Syst Rev","author":"W Simpson","year":"2012","unstructured":"Simpson W, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012, 3: CD005011"},{"issue":"10","key":"3067_CR17","first-page":"438","volume":"109","author":"I Matic","year":"2008","unstructured":"Matic I, Titlic M, Lucic I, Mirkovic F, Jurjevic M: Recombinant activated factor VII in refractory gastrointestinal haemorrhage of unknown aetiology. Bratisl Lek Listy. 2008, 109 (10): 438-440.","journal-title":"Bratisl Lek Listy"},{"issue":"Suppl 1","key":"3067_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.seminhematol.2003.11.019","volume":"1","author":"HR Roberts","year":"2004","unstructured":"Roberts HR, Monroe DM, Hoffman M: Safety profile of recombinant factor VIIa. Semin Hematol. 2004, 1 (Suppl 1): 101-108.","journal-title":"Semin Hematol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T11:19:10Z","timestamp":1598181550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3067"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-535","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]},"assertion":[{"value":"14 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"535"}}